ID: ALA2414974

Max Phase: Preclinical

Molecular Formula: C15H15N3

Molecular Weight: 237.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1cc2c(n1)-c1c(c3ccccc3n1C)CC2

Standard InChI:  InChI=1S/C15H15N3/c1-17-9-10-7-8-12-11-5-3-4-6-13(11)18(2)15(12)14(10)16-17/h3-6,9H,7-8H2,1-2H3

Standard InChI Key:  NCBDMHAAALYYBB-UHFFFAOYSA-N

Associated Targets(Human)

MAPK10 Tchem Mitogen-activated protein kinase 10/Receptor-interacting serine/threonine-protein kinase 1 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.31Molecular Weight (Monoisotopic): 237.1266AlogP: 2.68#Rotatable Bonds: 0
Polar Surface Area: 22.75Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.86CX LogP: 3.24CX LogD: 3.24
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.59Np Likeness Score: -0.51

References

1. Wu Z, Li Y, Cai Y, Yuan J, Yuan C..  (2013)  A novel necroptosis inhibitor-necrostatin-21 and its SAR study.,  23  (17): [PMID:23886688] [10.1016/j.bmcl.2013.06.073]

Source